dimethyl fumarate
biogen
['ease', 'modify']
#ectrims2022 late-breaking: #arise: 1st randomized clinical trial demonstrates benefit of disease modifying therapy in people with #ris. treatment with #dmf resulted in over 80% risk reduction vs placebo in prevention of first clinical event related to #cns #demyelination. 
Peer-reviewed. Multidisciplinary. Open access.
International Journal of MS Care: Consortium of Multiple Sclerosis Centers' official journal. (ISSN: 1537-2073)